Chemopotentiation in vivo: no loss of sensitization with fractionation (Q35991805)

11 August 2017

Chemopotentiation in vivo: no loss of sensitization with fractionation (English)

1 reference

11 August 2017

S A Hill

1

1 reference

11 August 2017

D W Siemann

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 October 1984

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

50

1 reference

11 August 2017

4

1 reference

11 August 2017

509-517

1 reference

Enhancing effect of misonidazole on the response of the RIF-1 tumour to cyclophosphamide

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

In vivo combination of misonidazole and the chemotherapeutic agent CCNU

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Enhancement of CCNU cytotoxicity by misonidazole: possible therapeutic gain

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Survival measurements at low doses: oxygen enhancement ratio

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Potentiation of chemotherapy by hypoxic cell radiation sensitizers--a review.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

The mechanisms of cytotoxicity and chemosensitization by misonidazole and other nitroimidazoles.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Modification of CCNU pharmacokinetics by misonidazole--a major mechanism of chemosensitization in mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Hypoxic cell radiosensitizers as potential adjuvants to conventional chemotherapy for the treatment of cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Hypoxic cells and in situ chemopotentiation of the nitrosoureas by misonidazole

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

The effect of radiosensitizers on the pharmacokinetics of melphalan and cyclophosphamide in the mouse

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Modification of tumour and host response to cyclophosphamide by misonidazole and by WR 2721

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Nitrosourea-misonidazole combination chemotherapy: Effect on KHT sarcomas, marrow stem cells and gut

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

Sensitization of mouse tumours using fractionated X-irradiation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

The effect of misonidazole in combination with radiation dose fractionation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

A new mouse tumor model system (RIF-1) for comparison of end-point studies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2: 95% O2) on the in vivo radiation response of a murine sarcoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976902

An in vitro assay to measure the viability of KHT tumor cells not previously exposed to culture conditions

11 July 2018

1 reference

12 December 2020

Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors

1 reference

12 December 2020

Dose fractionation studies with a murine sarcoma under conditions of air or carbogen (95% OI2 5% CO2) breathing

1 reference

12 December 2020

The interaction of misonidazole with radiation, chemotherapeutic agents, or heat: a preliminary report

1 reference

12 December 2020

In vivo tumor response to single and multiple exposures of adriamycin

1 reference

12 December 2020

Enhancement of chemotherapy agents

1 reference

12 December 2020

The effect of cytotoxic drugs with or without misonidazole on leucopenia in three strains of mice

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1984.208

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

6487517

1 reference